314 related articles for article (PubMed ID: 19036157)
21. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom DW; Stratford AL; Klinge U; Mertens PR; Chen CS; Bally M; Yapp D; Dunn SE
Mol Pharmacol; 2007 Sep; 72(3):641-52. PubMed ID: 17595327
[TBL] [Abstract][Full Text] [Related]
22. Stress-Induced Phosphorylation of Nuclear YB-1 Depends on Nuclear Trafficking of p90 Ribosomal S6 Kinase.
Tiwari A; Rebholz S; Maier E; Dehghan Harati M; Zips D; Sers C; Rodemann HP; Toulany M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126195
[TBL] [Abstract][Full Text] [Related]
23. P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation.
Li P; Goto H; Kasahara K; Matsuyama M; Wang Z; Yatabe Y; Kiyono T; Inagaki M
Mol Biol Cell; 2012 Apr; 23(8):1582-92. PubMed ID: 22357623
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1-Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells.
Lettau K; Zips D; Toulany M
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):567-580. PubMed ID: 32931865
[TBL] [Abstract][Full Text] [Related]
25. Two p90 ribosomal S6 kinase isoforms are involved in the regulation of mitotic and meiotic arrest in Artemia.
Duan RB; Zhang L; Chen DF; Yang F; Yang JS; Yang WJ
J Biol Chem; 2014 Jun; 289(23):16006-15. PubMed ID: 24755224
[TBL] [Abstract][Full Text] [Related]
26. The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.
Clark DE; Errington TM; Smith JA; Frierson HF; Weber MJ; Lannigan DA
Cancer Res; 2005 Apr; 65(8):3108-16. PubMed ID: 15833840
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of RSK1 characterizes high-grade gliomas with immune infiltration.
M Hajj GN; da Silva FF; de Bellis B; Lupinacci FCS; Bellato HM; Cruz JR; Segundo CNC; Faquini IV; Torres LC; Sanematsu PI; Begnami MD; Martins VR; Roffé M
Mol Oncol; 2020 Jan; 14(1):159-179. PubMed ID: 31701625
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of eukaryotic translation initiation factor 4B (EIF4B) by open reading frame 45/p90 ribosomal S6 kinase (ORF45/RSK) signaling axis facilitates protein translation during Kaposi sarcoma-associated herpesvirus (KSHV) lytic replication.
Kuang E; Fu B; Liang Q; Myoung J; Zhu F
J Biol Chem; 2011 Dec; 286(48):41171-41182. PubMed ID: 21994950
[TBL] [Abstract][Full Text] [Related]
29. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.
Jiang D; Qiu T; Peng J; Li S; Tala ; Ren W; Yang C; Wen Y; Chen CH; Sun J; Wu Y; Liu R; Zhou J; Wu K; Liu W; Mao X; Zhou Z; Chen C
Cell Death Differ; 2022 Jun; 29(6):1283-1295. PubMed ID: 35022570
[TBL] [Abstract][Full Text] [Related]
30. Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK.
Smith JA; Maloney DJ; Clark DE; Xu Y; Hecht SM; Lannigan DA
Bioorg Med Chem; 2006 Sep; 14(17):6034-42. PubMed ID: 16723233
[TBL] [Abstract][Full Text] [Related]
31. L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway.
Lommel MJ; Trairatphisan P; Gäbler K; Laurini C; Muller A; Kaoma T; Vallar L; Sauter T; Schaffner-Reckinger E
FASEB J; 2016 Mar; 30(3):1218-33. PubMed ID: 26631483
[TBL] [Abstract][Full Text] [Related]
32. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
Zhao Y; Bjorbaek C; Moller DE
J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
[TBL] [Abstract][Full Text] [Related]
33. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.
Shiota M; Itsumi M; Yokomizo A; Takeuchi A; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
Prostate; 2014 Jun; 74(8):829-38. PubMed ID: 24729449
[TBL] [Abstract][Full Text] [Related]
34. The RSK factors of activating the Ras/MAPK signaling cascade.
Carriere A; Ray H; Blenis J; Roux PP
Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
[TBL] [Abstract][Full Text] [Related]
35. Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation.
Toulany M; Schickfluss TA; Eicheler W; Kehlbach R; Schittek B; Rodemann HP
Breast Cancer Res; 2011 Mar; 13(2):R28. PubMed ID: 21392397
[TBL] [Abstract][Full Text] [Related]
36. Identifying requirements for RSK2 specific inhibitors.
Wright EB; Fukuda S; Li M; Li Y; O'Doherty GA; Lannigan DA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1798-1809. PubMed ID: 34348556
[TBL] [Abstract][Full Text] [Related]
37. Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.
Utepbergenov D; Derewenda U; Olekhnovich N; Szukalska G; Banerjee B; Hilinski MK; Lannigan DA; Stukenberg PT; Derewenda ZS
Biochemistry; 2012 Aug; 51(33):6499-510. PubMed ID: 22846040
[TBL] [Abstract][Full Text] [Related]
38. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
[TBL] [Abstract][Full Text] [Related]
39. Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.
Panupinthu N; Yu S; Zhang D; Zhang F; Gagea M; Lu Y; Grandis JR; Dunn SE; Lee HY; Mills GB
Oncogene; 2014 May; 33(22):2846-56. PubMed ID: 23851501
[TBL] [Abstract][Full Text] [Related]
40. Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.
Silverman E; Frödin M; Gammeltoft S; Maller JL
Mol Cell Biol; 2004 Dec; 24(24):10573-83. PubMed ID: 15572664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
